Mei‐Yu Hsu

2.6k citations
36 papers · 1.9k indexed · h-index 20
Topics
Cancer Cells and Metastasis (12 papers)Cell Adhesion Molecules Research (10 papers)melanin and skin pigmentation (6 papers)

In The Last Decade

Mei‐Yu Hsu

36 papers receiving 1.9k citations

Peers

Mei‐Yu Hsu
Comparison fields: 5 of 117
  • Molecular Biology 1.0k
  • Oncology 723
  • Cell Biology 456
  • Immunology and Allergy 300
  • Immunology 288
Replace Lorenzo Borgognoni with:
Lorenzo Borgognoni Italy
Witold W. Kilarski Switzerland
Rebecca L. Aucott United Kingdom
Anita J. Merritt United Kingdom
Susan R. Opalenik United States
Charlotte M. Vines United States
Edgar Dippel Germany
Janusz Franco‐Barraza United States
Κατερίνα Οικονομοπούλου Canada
Patrick J. Dowd United States
Mei‐Yu Hsu relative to Lorenzo Borgognoni Italy Lorenzo Borgognoni's profile →
Citations per field
00.5×3.7×
Lorenzo Borgognoni · 1×
Citations per year

Countries citing papers authored by Mei‐Yu Hsu

Since Specialization
Citations

This map shows the geographic impact of Mei‐Yu Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei‐Yu Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei‐Yu Hsu more than expected).

Fields of papers citing papers by Mei‐Yu Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei‐Yu Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei‐Yu Hsu. The network helps show where Mei‐Yu Hsu may publish in the future.

Co-authorship network of co-authors of Mei‐Yu Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Mei‐Yu Hsu. A scholar is included among the top collaborators of Mei‐Yu Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei‐Yu Hsu. Mei‐Yu Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 30
2 80
3 88
4 57
5 14
6 55
7 31
8 1
9 37
10 89
11 60
12 37
13 76
14 15
15 13
16 7
17 139
18 8
19 176
20 94

About Mei‐Yu Hsu

Mei‐Yu Hsu is a scholar working on Immunology and Allergy, Occupational Therapy and Issues, ethics and legal aspects, having authored 36 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (12 papers), Cell Adhesion Molecules Research (10 papers) and melanin and skin pigmentation (6 papers). The work is most often cited by research in Immunology and Allergy (300 citations), Cell Biology (456 citations) and Oncology (723 citations). Mei‐Yu Hsu has collaborated with scholars based in United States, Taiwan and United Kingdom. Frequent co-authors include Meenhard Herlyn, Friedegund Meier, Patricia Van Belle, David E. Elder, Mark E. Nesbit, Ju-Yu Hsu, Chiou-Yan Lai, Thomas Andl, Gang Li and Brian E. Schwartz. Their work appears in journals such as Cancer Research, Oncogene and Journal of Cell Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026